← FDA Drug Approvals (Drugs@FDA)
CLOBAZAM
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: AMNEAL · Approved 2018-10-22
Drug application
- FDA Application #
ANDA210039- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- CLOBAZAM
- Generic name
- CLOBAZAM
- Active ingredients
- CLOBAZAM
- Dosage form
- SUSPENSION
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- AMNEAL
- Manufacturer
- Amneal Pharmaceuticals NY LLC
- First approval
- 2018-10-22
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown